Business
OWC Pharmaceutical Research Corp Announces the Nominations of Ms. Miriam Sani, MSc Eng., to its Advisory Board
OWC Pharmaceutical Research Corp Announces the Nominations of Ms. Miriam Sani, MSc Eng., to its Advisory Board.
About this update from Owc Pharmaceutical Research Corp
[{"type":"text","content":"\n\n\n\nOWC Pharmaceutical Research Corp Announces the Nominations of Ms. Miriam Sani, MSc Eng., to its Advisory Board\n\n\n\n\n\nOWC Pharmaceutical Research Corp Announces the Nominations of Ms. Miriam Sani, MSc Eng., to its Advisory Board\nMSc Eng. Ms. Sani Brings 26 Years of Unique Bio-pharma Regulatory Expertise, Specializing in Production and Commercialization of Medical Solutions and Compliance With Regulatory Protocols\nPR Newswire\nPETACH TIKVA, Israel, January 27, 2017\n\n\n\nPETACH TIKVA, Israel, January 27, 2017 /PRNewswire/ --\n\nOWC Pharmaceutical Research Corp. (OTCQB: OWCP), (\"OWC\" or the \"Company\"), an Israeli-based developer of cannabinoid-based therapies targeting a variety of medical conditions and disorders, today announced that Ms. Miri Sani has accepted nomination to the Company's Advisory Board.\n\n     (Logo: http://mma.prnewswire.com/media/458036/OWC_Logo.jpg )\n\n\nMs. Sani, who received an MSc [Master of Science Degree) in Chemistry from the Technion - Israel Institute of Technology, Haifa, Israel, will advise OWC's management on the transition of its innovatively-developed cannabinoid products and delivery systems developed internally and through its hospital relationships, to full industrial and commercial production, in strict compliance with all local and state regulations and protocols, working closely with applicable healthcare agencies and ministries. Ms. Sani will also supervise all manufacturing facilities of third party licensees to assure for quality control in accordance with OWC protocols that were developed at leading hospitals in Israel, for a steady and long-lasting quality of products and measured dosages.\n\nMs. Sani is the CEO and owner of \"Shefa Amirim\" Ltd, which provides regulatory affairs and clinical consultation services for early-stage start-ups in various medical fields. Shefa Amirim provides clients with the requisite regulatory plans, designing and conducting the required clinical studies, CRO services and the preparation of technical files and related services necessary for FDA applications and approval. During the past five years, Ms. Sani has shepherded various projects and treatments in the areas of dermatology, proctology, cardio-vascular, ophthalmology, urology, cell therapy, OBYOGN and IVD's through both regulatory affairs and clin...